Eosinophilic bronchiolitis successfully treated with mepolizumab

被引：11

作者：

Takeshita, Yuichiro ^{[1
]}

Nobuyama, Seiichi ^{[2
]}

Kanetsuna, Yukiko ^{[3
]}

Tanaka, Akihiko ^{[4
]}

Adachi, Mitsuru ^{[5
]}

Sato, Tetsuo ^{[1
]}

Tada, Yuji ^{[1
]}

机构：

[1] Int Univ Hlth & Welfare, Atami Hosp, Dept Resp Med, 13-1 Higashikaigan Cho, Atami, Shizuoka 4130012, Japan

[2] Kansai Med Univ, Dept Resp Med, Osaka, Japan

[3] Int Univ Hlth & Welf, Atami Hosp, Dept Pathol, Atami, Shizuoka, Japan

[4] Showa Univ, Div Resp Med & Allergol, Dept Med, Sch Med, Tokyo, Japan

[5] Int Univ Hlth & Welf, Sanno Hosp, Clin Res Ctr, Tokyo, Japan

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2020年 / 8卷 / 03期

关键词：

HYPEREOSINOPHILIC OBLITERATIVE BRONCHIOLITIS;

D O I：

10.1016/j.jaip.2019.10.013

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1159 / +

页数：4

共 8 条

[1] Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, Elisabeth H.
Wenzel, Sally E.
Thompson, Philip J.
Prazma, Charlene M.
Keene, Oliver N.
Yancey, Steven W.
Ortega, Hector G.
Pavord, Ian D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) : 1189 - 1197
[2] Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome
Cordier, Jean-Francois
Cottin, Vincent
Khouatra, Chahera
Revel, Didier
Proust, Clement
Freymond, Nathalie
Thivolet-Bejui, Francoise
Glerant, Jean-Charles
[J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1126 - 1134
[3] New Targeted Therapies for Uncontrolled Asthma
Corren, Jonathan
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (05) : 1394 - 1403
[4] Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden
Ekstrom, Magnus
Nwaru, Bright, I
Hasvold, Pal
Wiklund, Fredrik
Telg, Gunilla
Janson, Christer
[J]. ALLERGY, 2019, 74 (11) : 2181 - 2190
[5] Fukushima Yasutsugu, 2010, Allergology International, V59, P87, DOI 10.2332/allergolint.09-CR-0114
[6] Chronic bronchiolitis with associated eosinophilic lung disease (eosinophilic bronchiolitis)
Takayanagi, N
Kanazawa, M
Kawabata, Y
Colby, TV
[J]. RESPIRATION, 2001, 68 (03) : 319 - 322
[7] Tang TT, 2015, EUR REV MED PHARMACO, V19, P2634
[8] Anti-interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis
Tomyo, Fuminori
Sugimoto, Naoya
Kawamoto, Masashi
Nagase, Hiroyuki
Yamaguchi, Masao
Ohta, Ken
[J]. RESPIROLOGY CASE REPORTS, 2019, 7 (02):

← 1 →